How the immune system affects severe heart artery disease
Part of Heart & circulation clinical trials.
This study looks at how the immune system acts in the artery walls of people with severe heart disease. It will use a special method to examine heart tissue samples from people who had a heart transplant or bypass surgery, which may help doctors find better ways to prevent or treat this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You either received a heart transplant because of severe artery disease, or you had coronary artery bypass surgery (also called CABG)
- Your age is between 40 and 75 years
- You do not have any autoimmune disease or chronic inflammatory condition
- You have not had cancer in the last 5 years and do not have active cancer
- You have not used immunosuppressive therapy (like steroids or certain biologics) in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how immune cells (macrophages) behave differently in patients with blocked arteries in the heart or legs. Understanding this may help doctors develop better treatments for these conditions.
This study looks at a treatment that affects signals between heart cells in people with severe coronary artery disease who are scheduled for bypass surgery. The goal is to see if changing these heart-cell signals can improve heart outcomes around the time of surgery.
This study looks at whether a comprehensive add-on treatment—starting with immune medicine and then a heart procedure when needed—can improve outcomes for people whose coronary artery disease is getting worse quickly. It focuses on cases where inflammation is likely driving new artery blockages or worsening chest pain.
This study looks at donated hearts that were not used for transplant because of artery disease. Researchers want to understand this condition better, which might help improve future heart transplants.
This study uses your blood to create special lab cells (induced pluripotent stem cells) to better understand heart-related differences between people with coronary artery disease and generally healthy older adults. It may help researchers learn what biological traits are linked to heart risk and how those traits work.
This study looks at tiny structures inside heart muscle cells (especially “power stations” in the cells) in people with certain types of heart failure who are getting coronary bypass surgery. It may help researchers better understand what changes happen in the heart and how this could guide future care.
Hear when a new Atherosclerosis of Coronary Artery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.